Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Nkarta announced it will host a webcast on November 9, 2026, to review initial clinical data from its Ntrust clinical program evaluating NKX019 in myositis and systemic sclerosis. The data is being presented at the American College of Rheumatology (ACR) Convergence 2026 conference. This filing serves as an announcement of the upcoming data presentation and webcast, but does not disclose the actual clinical results themselves.
MineralRite announced that FINRA has processed the Form 211 filed by its sponsoring broker-dealer, allowing for the initiation of priced quotations for RITE common stock in the over-the-counter market. This removes the 'Unsolicited Quotes Only' designation and follows a series of corporate milestones including the acquisition of Goldfield mining equipment rights and the filing of a Form 10 registration statement. The company also highlighted its progress on the Skull Valley project in Arizona and its exemption from 'penny stock' status.
The Mexico Fund, Inc. released its Monthly Summary Report for October 2026, disclosing total net assets of $335.9 million and a Net Asset Value (NAV) per share of $23.29. The report highlights that the Fund's NAV increased 3.3% during the month, underperforming the MSCI Mexico Index which rose 5.1%.
OneMedNet reported preliminary Q3 2026 revenue of approximately $1 million, a 465% increase year-over-year, driven by the scaling of its de-identified data delivery infrastructure. The company also provided Q4 2026 revenue guidance of $12 million to $14 million, reflecting a significant weighting of revenue toward the end of the year as it delivers on its expanded sales funnel.
BioCardia has completed the clinical consultation process with Japan's PMDA regarding application materials for its CardiAMP Cell Therapy System. This milestone allows the company to advance toward a formal marketing approval application for the treatment of ischemic heart failure in Japan, with initial patient treatments and commercial revenues targeted for 2028.
Encompass Health announced the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, following catastrophic flooding and patient evacuation on November 1-2, 2026. The company is evaluating options to refurbish or replace the facility with its joint venture partner, Holmes Regional Medical Center. Despite the closure, the company reaffirmed its full-year 2026 financial guidance.
Powerus Corporation provided a business and pipeline update, disclosing $130 million in executed purchase orders and contracts expected to be recognized as revenue within the next 12 months. The company also estimated its current total unweighted pipeline of revenue opportunities at approximately $4.5 billion, with a weighted pipeline of $334 million.
CVD Equipment provided a strategic update announcing it will no longer pursue new system orders and has engaged CBRE to market its real estate properties in New York for sale. The company also reported Q3 2026 operational metrics including revenue of $1.6 million and a cash balance of $23.5 million following its previous divestiture of SDC.
PodcastOne announced preliminary financial results for its second quarter and first half ended September 30, 2026, reporting record first-half revenue of $31.5 million. The company also disclosed that its Board has formed a special committee to evaluate inbound strategic acquisition interest from multiple parties. Additionally, the company highlighted its acquisition of PodcastOne.AI and its ranking as the No. 6 U.S. podcast publisher.
NuScale Power reported its third quarter 2026 operational results, highlighting a transition from development to physical production through a fabrication agreement with Doosan Enerbility. The company maintained a strong liquidity position with $1.9 billion in cash and investments while advancing its supply chain through AI tool deployment and reactor safety component fabrication.
Agassi Sports Entertainment Corp. entered into a merchandise license agreement with Rhino Entertainment LLC to manufacture and sell Grateful Dead branded pickleball and padel equipment and apparel. The company will pay royalties and guaranteed payments to Rhino, with a product rollout expected to begin in mid-2027. This agreement is part of the company's strategy to expand its lifestyle merchandise offering within the racket sports ecosystem.
INOVIO Pharmaceuticals provided a preliminary financial update for the quarter ended September 30, 2026, estimating its cash, cash equivalents, and short-term investments at approximately $48.4 million. This disclosure serves as a selective operational update ahead of its full quarterly financial report.
StepStone Group reported its second quarter fiscal year 2027 results for the period ended September 30, 2026, and declared a quarterly cash dividend of $0.33 per share. As of the quarter-end, the firm was responsible for approximately $958 billion of total capital, including $261 billion in assets under management. Although filed under Item 2.02, the press release contains only selective operational metrics and lacks a formal GAAP income statement.
Bruker Corporation completed a reorganization of its reportable segments to streamline its organizational structure, effective July 1, 2026. The company recast its historical segment financial information for 2024, 2025, and 2026 to conform to the new structure, which now includes BSI BIOS and BSI Microbiology and Infection Diagnostics (BMID).
Airbnb provided an operational update for Q3 2026, highlighting the shipment of over 50 new products and features including expanded 'Connections' and 'Neighborhood' pages. The company also detailed its expansion into hotels, car rentals, and a new exclusive partnership with American Express to list Airbnb stays on AmexTravel.com.
Acumen Pharmaceuticals is implementing a major restructuring plan that includes reducing its workforce by approximately 90% (52 employees) following the decision to cease development of its lead candidate, sabirnetug. The company estimates it will incur $7.75 million in severance-related charges and has also fully repaid its $23.3 million outstanding debt to K2 HealthVentures to conserve cash while evaluating strategic options.
Microbot Medical announced that the Canadian Intellectual Property Office granted a patent for an adaptor used in its LIBERTY Endovascular Robotic System. This grant brings the company's global intellectual property portfolio to 45 issued patents and 48 pending applications, supporting its strategy for international commercialization expansion.
Processa Pharmaceuticals issued a stockholder letter outlining its strategic shift toward immunological and inflammatory (I&I) diseases following its July acquisition of Vidya Therapeutics. The company highlighted the advancement of its lead BTK inhibitor candidate, VT-7208, into Phase 2 development for food allergy, chronic spontaneous urticaria, and relapsing multiple sclerosis, supported by approximately $183.3 million in net cash proceeds.
Home BancShares received an $80.7 million payment from a borrower following the sale of collateral securing a major $92.1 million non-performing lending relationship in Texas. This payment completes the first phase of the credit resolution, reducing the company's non-performing loan ratio by approximately 48 basis points and leaving a remaining carrying balance of $11.4 million.
Intensity Therapeutics reported its Q3 2026 financial results and provided an operational update on its clinical pipeline, including the resumption of patient enrollment in the Phase 3 INVINCIBLE-3 soft tissue sarcoma study and the Phase 2 INVINCIBLE-4 triple-negative breast cancer study. The company ended the quarter with $8.5 million in cash and cash equivalents.
Enovix announced a cost reduction plan involving a reduction of approximately 220 positions (23% of its workforce) to save $8.5 million annually. The company is rebalancing its operations to focus on its South Korean plant, where it is investing $19 million to double capacity for drone and defense batteries to meet a $216 million pipeline.
Sunshine Silver Mining & Refining completed its 50,000-meter infill drill program at the Sunshine Mine in Idaho, reporting high-grade silver results exceeding 1,000 gpt across multiple veins. The data will support an updated Mineral Resource Estimate in Q1 2027 and a Feasibility Study in Q2 2027 as the company targets a return to production in late 2028.
MidCap Financial Investment Corp reported its Q3 2026 operational results, highlighting a net asset value (NAV) of $12.86 per share and net investment income of $0.34 per share. The company also noted its pending acquisition by Ares Capital Corporation (ARCC) and declared a quarterly dividend of $0.31 per share.
World Financial Network Credit Card Master Note Trust Business Update
Comenity Capital Bank and Comenity Servicing LLC entered into a First Addendum to their Seventh Amended and Restated Service Agreement to modify specific services and performance standards. The amendments update enterprise architecture strategy and issues management protocols, including remediation planning and risk oversight. This filing represents a routine operational update to the bank's outsourced service framework.
Service Properties Trust announced its third quarter 2026 financial results and posted an updated investor presentation to its website. The company, which has $9.6 billion invested in retail net lease properties and hotels, will host a conference call on November 5, 2026, to discuss the results.
Annovis Bio provided a preliminary estimate of its cash and cash equivalents, which were approximately $2.8 million as of September 30, 2026. The company noted that it has not yet completed its quarterly financial closing processes and the figure is subject to change upon completion of its full interim financial statements.
Cencora, Inc. announced a reorganization of its operating model and reporting structure to advance growth priorities and improve visibility. Beginning in fiscal 2027, the company will report results across three segments: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other. The filing includes supplemental unaudited historical segment data for fiscal 2025 and 2026 recast under this new structure to assist investor analysis.
Royale Energy announced that its common stock will commence trading on the OTCQB Venture Market effective November 4, 2026. This follows the company's successful restoration of SEC reporting compliance and is intended to enhance transparency and investor access.
HarbourVest Private Equity Secondaries Fund Business Update
HarbourVest Private Equity Secondaries Fund (TE) L.P. finalized its transactional net asset values (NAV) for its limited partnership units as of September 30, 2026. The Fund reported an aggregate transactional NAV of approximately $2.0 million, with Class I units valued at $10.27 per unit.
Federated Hermes, Inc. announced a proposed restructuring of its London-based subsidiary, Federated Hermes Limited, involving the elimination or transfer of approximately 200 positions. The company expects to incur $15 million in pre-tax restructuring charges through 2027 but anticipates achieving approximately $30 million in annual pre-tax cost savings upon completion.